Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koji Kamikozuru

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 20, 2018
CytapheresisYoko Yokoyama, Koji Kamikozuru, Shiro Nakamura
Cytokine|January 2, 2018
Inflammatory bowel disease patients experiencing a loss of response to infliximab regain long-term response after undergoing granulocyte/monocyte apheresis: A case seriesYoko Yokoyama, Koji Kamikozuru, Kenji Watanabe, et al.
Chemical Senses|December 19, 2024
Clinical features of taste disorders in Cronkhite-Canada syndrome: a report of 10 casesTomomi Nin, Koji Kamikozuru, Tetsuya Takagawa, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|October 11, 2013
Questionnaire based assessment of patients' acceptability of leukocytapheresis for the treatment of inflammatory bowel diseaseKazuko Nagase, Ken Fukuanga, Yoko Yokoyama, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 7, 2011
Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel DiseaseTakayuki Matsumoto, Ken Fukunaga, Koji Kamikozuru, et al.
Journal of Clinical Apheresis|June 15, 2010
Selective depletion of peripheral granulocyte/monocyte enhances the efficacy of scheduled maintenance infliximab in Crohn's diseaseKen Fukunaga, Yoko Yokoyama, Koji Kamikozuru, et al.
Journal of Gastroenterology and Hepatology|July 11, 2012
Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitisKen Fukunaga, Yoshio Ohda, Nobuyuki Hida, et al.
Digestion|November 14, 2019
Efficacies and Related Issues of Ustekinumab in Japanese Patients with Crohn's Disease: A Preliminary StudyTakako Miyazaki, Kenji Watanabe, Kentaro Kojima, et al.
Cytotherapy|April 10, 2014
Crohn's disease complicated by hepatitis B virus successfully treated with the use of adsorptive depletion of myeloid lineage leucocytes to suppress inflammatory cytokine profileYoko Yokoyama, Ken Fukunaga, Koji Kamikozuru, et al.
World Journal of Gastroenterology|April 25, 2024
Real-world efficacy and safety of tofacitinib treatment in Asian patients with ulcerative colitisKentaro Kojima, Kenji Watanabe, Mikio Kawai, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 20, 2018
CytapheresisYoko Yokoyama, Koji Kamikozuru, Shiro Nakamura
Cytokine|January 2, 2018
Inflammatory bowel disease patients experiencing a loss of response to infliximab regain long-term response after undergoing granulocyte/monocyte apheresis: A case seriesYoko Yokoyama, Koji Kamikozuru, Kenji Watanabe, et al.
Chemical Senses|December 19, 2024
Clinical features of taste disorders in Cronkhite-Canada syndrome: a report of 10 casesTomomi Nin, Koji Kamikozuru, Tetsuya Takagawa, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|October 11, 2013
Questionnaire based assessment of patients' acceptability of leukocytapheresis for the treatment of inflammatory bowel diseaseKazuko Nagase, Ken Fukuanga, Yoko Yokoyama, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 7, 2011
Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel DiseaseTakayuki Matsumoto, Ken Fukunaga, Koji Kamikozuru, et al.
Journal of Clinical Apheresis|June 15, 2010
Selective depletion of peripheral granulocyte/monocyte enhances the efficacy of scheduled maintenance infliximab in Crohn's diseaseKen Fukunaga, Yoko Yokoyama, Koji Kamikozuru, et al.
Journal of Gastroenterology and Hepatology|July 11, 2012
Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitisKen Fukunaga, Yoshio Ohda, Nobuyuki Hida, et al.
Digestion|November 14, 2019
Efficacies and Related Issues of Ustekinumab in Japanese Patients with Crohn's Disease: A Preliminary StudyTakako Miyazaki, Kenji Watanabe, Kentaro Kojima, et al.
Cytotherapy|April 10, 2014
Crohn's disease complicated by hepatitis B virus successfully treated with the use of adsorptive depletion of myeloid lineage leucocytes to suppress inflammatory cytokine profileYoko Yokoyama, Ken Fukunaga, Koji Kamikozuru, et al.
World Journal of Gastroenterology|April 25, 2024
Real-world efficacy and safety of tofacitinib treatment in Asian patients with ulcerative colitisKentaro Kojima, Kenji Watanabe, Mikio Kawai, et al.
Pageof 4